Personal Genome Diagnostics snags $75 mln Series B

Personal Genome Diagnostics Inc has raised $75 million in Series B financing. Bristol-Myers Squibb and New Enterprise Associates led the round with participation from other investors that included Inova Strategic Investments, Helsinn Investment Fund, Windham Venture Partners and Maryland Venture Fund. Based in Baltimore, Personal Genome Diagnostics is a developer of regulated tissue-based and liquid biopsy genomic products for laboratories.

Source: Press Release